Physician profile
Aela Paiz
NPI 1689817892
$131,338.23
in general payments reported to CMS, 2019-2025
8 companies · $8,964 in 2025
The $8,964 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $14K · 2021: $32K · 2022: $36K · 2023: $1,433 · 2024: $27K · 2025: $8,964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $29K · Honoraria: $3,404 · Consulting Fee: $3,360 · Food and Beverage: $698 · Travel and Lodging: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $29,246.97 |
| Honoraria | $3,404.00 |
| Consulting Fee | $3,360.00 |
| Food and Beverage | $697.71 |
| Travel and Lodging | $586.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $90,739.98 | 2021-2025 | Nexplanon, Jada System |
| Merck Sharp & Dohme LLC | $28,835.17 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $11,438.60 | 2019-2025 | |
| Coopersurgical, INC. | $163.84 | 2023 | Summit Doppler |
| Roche Diagnostics Corporation | $64.80 | 2019-2020 | |
| Gilead Sciences, INC. | $44.85 | 2019 | |
| Pfizer INC. | $36.11 | 2019-2024 | |
| Cranial Technologies, INC | $14.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aela Paiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.